Form 4: AIM ImmunoTech Director Acquires Shares in Lieu of Cash Compensation

Director Nancy Bryan acquired 44,899 shares of AIM ImmunoTech Inc. common stock on March 14, 2025, in lieu of cash compensation under the company's Cash Conservation Plan.

Summary

• On March 14, 2025, Nancy Bryan, a director of AIM ImmunoTech Inc., acquired 44,899 shares of common stock.
• The shares were acquired at a price of $0.116 per share.
• This acquisition was made in lieu of director compensation, as part of the issuer's Cash Conservation Plan.
• Following the transaction, Ms. Bryan directly owns 291,882 shares of AIM ImmunoTech Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral. While a director taking shares can be seen as a positive sign, it's also indicative of the company's need to conserve cash. The transaction itself is routine and doesn't necessarily indicate a significant shift in the company's prospects.

Positives

• The director's acceptance of shares in lieu of cash compensation demonstrates confidence in the company's future prospects.
• The Cash Conservation Plan helps the company manage its cash flow.

Industry Context

Directors sometimes take shares in lieu of cash, especially for smaller companies, to preserve cash. This is a common practice in the biotech industry, where companies often have limited cash reserves and are focused on research and development.

Related Party Transactions

• The acquisition of shares by Nancy Bryan, a director, in lieu of cash compensation is a related party transaction.

Stakeholder Impact

• Shareholders may view the Cash Conservation Plan positively as it helps preserve the company's cash reserves.
• Employees may be indirectly affected if the company's cash position improves due to the plan.

Key Dates